Exploratory Study of the Efficacy of HAL-PDT in CIN 3 | MicrobiomeTrials← Back to trialsNCT07891338
Exploratory Study of the Efficacy of HAL-PDT in CIN 3
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2028-06
Enrollment target: 260 participants Locations- Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China
Other microbiome trials you might be interested in
HSIL, High Grade Squamous Intraepithelial LesionDNA MethylationCIN - Cervical Intraepithelial Neoplasia
The goal of this observational study (retrospective cohort study) is to determine whether DNA methylation status in arch…
Lund, SwedenEst. completion Jun 2027
Triple-negative Breast CancerTNBC - Triple-Negative Breast Cancer
About 10-20% of all individuals with breast cancer have a so-called triple-negative tumor (TNBC). This type of breast ca…
Lyon, FranceEst. completion Oct 2028